#HVO hVIVO PLC – hMPV challenge model update January 13, 2025 – Posted in: hVIVO (HVO)

Highlights ·    hVIVO successfully completes pilot hMPV characterisation study ·    Study exhibited strong infectivity rate and induced symptomatic disease in healthy volunteers ·    Now marketing for hMPV challenge trials to support the development of hMPV vaccines and antivirals ·    Dr Andrew Catchpole to present data from the study at the 13th International RSV Symposium in Brazil   hVIVO plc (AIM: HVO), a fast-growing specialist contract research organisation (CRO) and world leader in testing infectious and…

Continue reading